[HTML][HTML] Chinese guideline on allergen immunotherapy for allergic rhinitis: the 2022 update

C Wang, Y Bao, J Chen, X Chen, L Cheng… - Allergy, Asthma & …, 2022 - ncbi.nlm.nih.gov
In the last few decades, there has been a progressive increase in the prevalence of allergic
rhinitis (AR) in China, where it now affects approximately 250 million people. AR prevention …

Organ‐specific allergen challenges in airway allergy: current utilities and future directions

JL Fauquert, C Alba‐Linero, A Gherasim… - Allergy, 2023 - Wiley Online Library
Atopy has been long used as the screening method for airway allergy. Nevertheless,
aeroallergens can trigger respiratory symptoms not only in atopic patients (atopic respiratory …

Nasal steroid spray simulations using measured spray characteristics in healthy and rhinitic nasal passages

JS Kimbell, GJM Garcia, JD Schroeter, P Sheth… - Journal of Aerosol …, 2023 - Elsevier
Intranasal corticosteroid sprays (ICSs) are frequently prescribed for allergic rhinitis (AR),
which is the fifth most common chronic disease in the United States. This study aimed to …

Healthcare utilisation and economic burden of migraines among bank employees in China: a probabilistic modelling study

D Wei, LP Wong, X He, T Loganathan - The Journal of Headache and Pain, 2024 - Springer
Background Despite the recognised high prevalence of migraines among bank employees,
yet their healthcare utilisation patterns and the economic burden of migraines remain …

[HTML][HTML] Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised …

Y Zhang, B Yan, Z Zhu, X Wang, X Song, D Zhu… - …, 2024 - thelancet.com
Background There is no trial to assess the benefits of periodically using biologics during the
pollen season in patients with uncontrolled seasonal allergic rhinitis (SAR), who have …

Highlights of the treatment of allergic rhinitis according to Chinese guidelines

M Zhang, T Ao, L Cheng - Current Opinion in Allergy and Clinical …, 2023 - journals.lww.com
Highlights of the treatment of allergic rhinitis according t... : Current Opinion in Allergy and
Clinical Immunology Highlights of the treatment of allergic rhinitis according to Chinese …

Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure

K Wang, Y Zhang, L Wan, J Li, C Wang… - Allergy and Asthma …, 2024 - ingentaconnect.com
Background: Allergic rhinitis (AR) is traditionally subdivided into seasonal AR (SAR) and
perennial AR (PAR) according to the type of allergen and the occurrence of symptoms …

Long-acting anti-inflammatory injectable DEX-Gel with sustained release and self-healing properties regulates TH1/TH2 immune balance for minimally invasive …

L Dai, B Liu, J Lin, Y Jiang, Y Li, Z Yao, S Shen… - Journal of …, 2024 - Springer
Background Allergic rhinitis (AR) is a prevalent immune-related allergic disease, and
corticosteroid nasal sprays serve as the primary treatment for this patient population …

Exploring associations between short-term air pollution and daily outpatient visits for allergic rhinitis

W Tang, L Sun, J Wang, K Li, S Liu… - … and Healthcare Policy, 2023 - Taylor & Francis
Purpose Many studies have reported that exposure to air pollution increases the likelihood
of acquiring allergic rhinitis (AR). This study investigated associations between short-term air …

[HTML][HTML] Blood and local eosinophil levels in chronic rhinitis: Observations during seasonal allergen exposure and non-exposure

X Xu, J Li, X Zhang, L Xi, Y Gao, X Li, Y Zhang… - World Allergy …, 2024 - Elsevier
Background Allergic rhinitis (AR) is a typical type 2 inflammatory disease and eosinophils
play a critical role of cardinal effectors in type 2 inflammation. However, the distribution of …